Hypercalcaemia as the initial presentation of Graves' disease

BMJ Case Rep. 2022 Aug 19;15(8):e251454. doi: 10.1136/bcr-2022-251454.

Abstract

Hypercalcaemia in patients with hyperthyroidism is usually asymptomatic. It occurs due to increased bone turnover and demineralisation. There are only a few case reports where symptomatic hypercalcaemia was the presenting complaint of hyperthyroidism. An Asian man in his 40s presented to us with intractable vomiting for the last 6 months which was not controlled despite multiple antiemetic medications. On routine biochemistry performed at our institute, he was found to have hypercalcaemia and concomitant hyperthyroidism. Classical symptoms suggestive of hyperthyroidism were not present in our patient thus delaying the diagnosis. His symptoms resolved after the correction of hypercalcaemia. Hypercalcaemia did not recur after achieving an euthyroid status on treatment with carbimazole. Other common and more sinister causes for hypercalcaemia like malignancy were ruled out. This case highlights that symptomatic hypercalcaemia could be the initial presentation of hyperthyroidism and amelioration of hyperthyroidism corrects the hypercalcaemia.

Keywords: General practice / family medicine; Thyroid disease.

Publication types

  • Case Reports

MeSH terms

  • Antithyroid Agents / therapeutic use
  • Carbimazole / therapeutic use
  • Graves Disease* / complications
  • Graves Disease* / diagnosis
  • Graves Disease* / drug therapy
  • Humans
  • Hypercalcemia* / diagnosis
  • Hypercalcemia* / drug therapy
  • Hypercalcemia* / etiology
  • Hyperthyroidism* / complications
  • Hyperthyroidism* / diagnosis
  • Hyperthyroidism* / drug therapy
  • Male

Substances

  • Antithyroid Agents
  • Carbimazole